(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

2-((4S)-6-(4-CLOROFENIL)-1-METIL-4HBENZO[C]ISOXAZOLO[4,5-E]AZEPIN-4-IL)ACETAMIDA PARA TRATAMENTO DE TROMBOCITEMIA

Em AnáliseInvention PatentPCT · US2021044318

Application data

Number

112023002134

Type

Invention Patent

Filing

08/03/2021

Publication

03/07/2023

PCT

US2021044318

Progress at the INPI

  1. Filing08/03/21
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 08/03/2021. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 03/07/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

CONSTELLATION PHARMACEUTICALS, INC.

US

See this company's full portfolio

Inventors

A. S. (pessoa física)

US

Technical data

Priority claims

US

63/060,723 · 08/04/2020

Abstract

2-((4S)-6-(4-CLOROFENIL)-1-METIL-4H-BENZO[C]ISOXAZOLO[4,5-E]AZEPIN-4-IL)ACETAMIDA PARA TRATAMENTO DE TROMBOCITEMIA. A presente invenção refere-se ao uso de 2-((4S)-6-(4-clorofenil)-l-metil -4 H-benzo [c] isoxazolo [4,5-e] azepin-4-il) acetamida, e seus sais farmaceuticamente aceitáveis, para o tratamento de trombocitemia.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

03/07/2023

RPI 2722

Alteração de dados cadastrais

#1.1

02/14/2023

RPI 2719

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.